Plunkett Research Online: Bioniche Life Sciences Inc

BIONICHE LIFE SCIENCES INC (BNC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Bioniche has developed a technology for the treatment of human cancers. The first product developed from this technology is Urocidin™, a formulation of Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, previously known as MCC suspension, for the treatment of human bladder cancer. The t.....


BIONICHE LIFE SCIENCES INC

Ticker: BNC
Exchange: TSE
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 613 966-8058
Fax: 613 966-4177
Address: 231 Dundas St E
Belleville, ON K8N 5J2 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Jennifer SheaAssistant Secretary/Vice President, Divisional
Michael BerendtCEO/Director/Other Executive Officer
See More
Bioniche has developed a technology for the treatment of human cancers. The first product developed from this technology is Urocidin™, a formulation of Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, previously known as MCC suspension, for the treatment of human bladder cancer. The t.....See More See More

$USD, In whole numbers 2016201520142013201220112010
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture